5-(chloromethyl)-1,3-dimethyl-1H-pyrazole → 1-((1,3-dimethyl-1H-pyrazol-5-yl)methyl)-3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1H-pyrazol-4-yl)-5,5-dimethylimidazolidine-2,4-dione

HRID 1770620

Reaktionsgleichung

Reaktionsgleichung von HRID 1770620
[CH3:1][C:2]1[C:6]([CH2:7][N:8]2[CH:12]=[C:11]([N:13]3[C:17](=[O:18])[C:16]([CH3:20])([CH3:19])[NH:15][C:14]3=[O:21])[CH:10]=[N:9]2)=[C:5]([CH3:22])[O:4][N:3]=1.Cl[CH2:24][C:25]1[N:29]([CH3:30])[N:28]=[C:27]([CH3:31])[CH:26]=1>>[CH3:30][N:29]1[C:25]([CH2:24][N:15]2[C:16]([CH3:19])([CH3:20])[C:17](=[O:18])[N:13]([C:11]3[CH:10]=[N:9][N:8]([CH2:7][C:6]4[C:2]([CH3:1])=[N:3][O:4][C:5]=4[CH3:22])[CH:12]=3)[C:14]2=[O:21])=[CH:26][C:27]([CH3:31])=[N:28]1

Komponenten

3

Edukt 2

HCID 49612705-(chloromethyl)-1,3-dimethyl-1H-pyrazoleHCID 595243883-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1H-pyrazol-4-yl)-5,5-dimethylimidazolidine-2,4-dione

Produkt 1

HCID 533739581-((1,3-dimethyl-1H-pyrazol-5-yl)methyl)-3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1H-pyrazol-4-yl)-5,5-dimethylimidazolidine-2,4-dione

Versuchsvorschrift

Prepared as in Example 12-16 from 3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1H-pyrazol-4-yl)-5,5-dimethylimidazolidine-2,4-dione (Example 12-16a) and 5-(chloromethyl)-1,3-dimethyl-1H-pyrazole. MS 412 (MH+). The title compound was shown to inhibit hT2R08 bitter receptor and had an 1050 of 0.23 μM.

Quellen und Nachweise

ORD-Eintrag
ord-660c4cb76b444b9181d39aaa2392c08e
Quelldatensatz
uspto-grants-2016_02
Patentnummer
US09247759B2

Verknüpfte Notizen

Wird geladen…